In a groundbreaking step forward for neurotechnology, Canadian neurosurgeons in Toronto, in collaboration with Elon Musk’s Neuralink, have received Health Canada’s approval to recruit six patients with paralysis for brain implant trials. This innovative study, called the CAN-PRIME trial, aims to test the safety and effectiveness of Neuralink’s brain-computer interface, which enables users to control devices with their thoughts.
Led by Toronto’s University Health Network neurosurgeon Andres Lozano, the trial will use a specialized surgical robot to implant 64 electrodes into the hand-motor regions of patients’ brains. Each electrode, equipped with 16 contact points, is designed to capture brain activity associated with movement, allowing patients to move connected devices by simply thinking about it. Neuralink, which has previously implanted similar devices in U.S. patients, will oversee the device design and signal decoding, while Canadian surgeons will handle patient selection and procedural safety.
Eligible participants must have severe quadriplegia due to ALS or spinal cord injuries. According to Lozano, surgeries will be performed in Toronto, with the technology enabling patients to control devices from the comfort of their homes. Lozano aims to start surgeries in early 2025, marking a significant milestone in brain-computer interface research.
While this technology has immense potential, Lozano and experts caution that it is still years away from general public availability. Ethical concerns, particularly regarding data security and the theoretical risk of external manipulation, underscore the importance of implementing stringent safeguards. “We must ensure this technology is developed safely and responsibly,” Lozano emphasized.
This breakthrough marks a notable step toward a future where brain implants could restore movement and communication capabilities to individuals with paralysis, showcasing both Canada’s leadership in neurotechnology and Musk’s ambitious vision for Neuralink.
Source: Swifteradio.com
